C2N Diagnostics EU ApS: Financial statements 2025
CVR: 45009092
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
C2N Diagnostics EU ApS (CVR 45009092) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -129,956 and a net result of DKK -140,078. Equity in the 2025 report amounted to DKK -202,154. The company had 1 employee in the financial year.
- Gross Profit
- DKK -129,956
- Profit/Loss
- DKK -140,078
- Equity
- DKK -202,154
- Total Assets
- DKK 40,000
- Employees
- 1
How creditworthy is C2N Diagnostics EU ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
C2N Diagnostics EU ApS has published its interim report for the period August 9, 2024 – December 31, 2024.
About C2N Diagnostics EU ApS
C2N Diagnostics EU ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2024. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Dr. Joel B. Braunstein. The company is owned by C2N Global, Inc. In 2025, the company reported a gross profit of DKK -129,956 and a net result of DKK -140,078. Equity in the 2025 report amounted to DKK -202,154.